Diabetes and gene therapy: from lab bench to bedside

Professor Ann Simpson, UTS School of Life Sciences and Centre for Health Technologies, is a leading Australian diabetes researcher who has developed an artificial insulin producing cell to treat Type 1 diabetes, an autoimmune disease that destroys the insulin-producing cells in the pancreas. Together with industry partner Pharmocyte Biotech Ann’s research aims to develop translational biotherapies that can be tailored to individual patients at the bedside.